Iroko Pharmaceuticals Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 290

Employees

  • Latest Deal Type
  • Out of Business

Iroko Pharmaceuticals General Information

Description

Developer of pharmaceutical products designed to provide responsible pain management services to patients. The company's products use proprietary technology to develop new drug products based on existing NSAIDs to relieve pain at low doses, enabling patients to lead a healthy and improved life.

Contact Information

Website
www.iroko.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 150 Rouse Boulevard
  • Philadelphia, PA 19112
  • United States
+1 (267)
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 150 Rouse Boulevard
  • Philadelphia, PA 19112
  • United States
+1 (267)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Iroko Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 16-Dec-2020 Completed Out of Business
4. Debt Refinancing 15-Jun-2016 Completed Generating Revenue
3. Debt - General 21-Nov-2013 Completed Clinical Trials - Phase 3
2. IPO 31-Jul-2013 $101M Cancelled Clinical Trials - Phase 2
1. Early Stage VC 06-Oct-2010 Completed Startup
To view Iroko Pharmaceuticals’s complete valuation and funding history, request access »

Iroko Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceutical products designed to provide responsible pain management services to patients. The company's
Drug Delivery
Philadelphia, PA
290 As of 2016

Morristown, NJ
 

Tampa, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Iroko Pharmaceuticals Competitors (22)

One of Iroko Pharmaceuticals’s 22 competitors is Alvogen Group, a Private Equity-Backed company based in Morristown, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alvogen Group Private Equity-Backed Morristown, NJ
Pacira BioSciences Formerly VC-backed Tampa, FL
Semnur Pharmaceuticals Formerly VC-backed Palo Alto, CA
Assertio Holdings Formerly VC-backed Lake Forest, IL
Centrexion Therapeutics Venture Capital-Backed Boston, MA
You’re viewing 5 of 22 competitors. Get the full list »

Iroko Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Iroko Pharmaceuticals Investments & Acquisitions (4)

Iroko Pharmaceuticals’s most recent deal was a Merger/Acquisition with iCeutica. The deal was made on 28-Apr-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
iCeutica 28-Apr-2011 Merger/Acquisition Drug Discovery
Merck & Co. (Non-US Commercial Rights of Aggrastat) 30-Jan-2008 Corporate Asset Purchase Buildings and Property
Eli Lilly Canada (Rights of Vancocin in Canada) 11-Sep-2007 Corporate Asset Purchase Buildings and Property
Merck & Co. (2 Pharmaceutical Products in the United States) 26-Mar-2007 Corporate Asset Purchase Buildings and Property
To view Iroko Pharmaceuticals’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Iroko International

Iroko Pharmaceuticals FAQs

  • When was Iroko Pharmaceuticals founded?

    Iroko Pharmaceuticals was founded in 2007.

  • Where is Iroko Pharmaceuticals headquartered?

    Iroko Pharmaceuticals is headquartered in Philadelphia, PA.

  • What is the size of Iroko Pharmaceuticals?

    Iroko Pharmaceuticals has 290 total employees.

  • What industry is Iroko Pharmaceuticals in?

    Iroko Pharmaceuticals’s primary industry is Drug Delivery.

  • Is Iroko Pharmaceuticals a private or public company?

    Iroko Pharmaceuticals is a Private company.

  • What is Iroko Pharmaceuticals’s current revenue?

    The current revenue for Iroko Pharmaceuticals is .

  • How much funding has Iroko Pharmaceuticals raised over time?

    Iroko Pharmaceuticals has raised $215M.

  • Who are Iroko Pharmaceuticals’s competitors?

    Alvogen Group, Pacira BioSciences, Semnur Pharmaceuticals, Assertio Holdings, and Centrexion Therapeutics are some of the 22 competitors of Iroko Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »